Metabolites
Displaying compounds 14176 - 14200 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB12697 | DG(10:0/24:0/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl tetracosanoate | C37H72O5 596.978 | |
| YMDB12722 | DG(12:0/22:0/0:0) | (2R)-1-(dodecanoyloxy)-3-hydroxypropan-2-yl docosanoate | C37H72O5 596.978 | |
| YMDB12747 | DG(14:0/20:0/0:0) | (2R)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl icosanoate | C37H72O5 596.978 | |
| YMDB13344 | Lyso-PI(18:2(9Z,11Z)/0:0) | {2-hydroxy-3-[(9Z,11Z)-octadeca-9,11-dienoyloxy]propoxy}[(2,3,4,5,6-pentahydroxycyclohexyl)oxy]phosphinic acid | C27H49O12P 596.651 | |
| YMDB13353 | Lyso-PI(0:0/18:2(9Z,11Z)) | {3-hydroxy-2-[(9Z,11Z)-octadeca-9,11-dienoyloxy]propoxy}[(2,3,4,5,6-pentahydroxycyclohexyl)oxy]phosphinic acid | C27H49O12P 596.651 | |
| YMDB15438 | PS(10:0/12:0) | (2S)-2-amino-3-({[(2R)-3-(decanoyloxy)-2-(dodecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid | C28H54NO10P 595.711 | |
| YMDB01662 | Cyanidin 3-O-(coumaroylglucoside) | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium | C30H27O13 595.5276 | |
| YMDB01129 | DG(16:0/18:1(9Z)/0:0) | (2R)-1-(hexadecanoyloxy)-3-hydroxypropan-2-yl (9Z)-octadec-9-enoate | C37H70O5 594.962 | |
| YMDB12918 | DG(16:0/18:1(11Z)/0:0) | (2R)-1-(hexadecanoyloxy)-3-hydroxypropan-2-yl (11Z)-octadec-11-enoate | C37H70O5 594.962 | |
| YMDB12946 | DG(16:1(11Z)/18:0/0:0) | (2R)-1-[(11Z)-hexadec-11-enoyloxy]-3-hydroxypropan-2-yl octadecanoate | C37H70O5 594.962 | |
| YMDB12698 | DG(10:0/24:1(11Z)/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl (11Z)-tetracos-11-enoate | C37H70O5 594.962 | |
| YMDB12699 | DG(10:0/24:1(9Z)/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl (9Z)-tetracos-9-enoate | C37H70O5 594.962 | |
| YMDB12975 | DG(16:1(9Z)/18:0/0:0) | (2R)-1-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropan-2-yl octadecanoate | C37H70O5 594.962 | |
| YMDB12723 | DG(12:0/22:1(11Z)/0:0) | (2R)-1-(dodecanoyloxy)-3-hydroxypropan-2-yl (11Z)-docos-11-enoate | C37H70O5 594.962 | |
| YMDB12724 | DG(12:0/22:1(9Z)/0:0) | (2R)-1-(dodecanoyloxy)-3-hydroxypropan-2-yl (9Z)-docos-9-enoate | C37H70O5 594.962 | |
| YMDB12748 | DG(14:0/20:1(11Z)/0:0) | (2R)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (11Z)-icos-11-enoate | C37H70O5 594.962 | |
| YMDB12749 | DG(14:0/20:1(13Z)/0:0) | (2R)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (13Z)-icos-13-enoate | C37H70O5 594.962 | |
| YMDB12774 | DG(14:1(11Z)/20:0/0:0) | (2R)-1-hydroxy-3-[(11Z)-tetradec-11-enoyloxy]propan-2-yl icosanoate | C37H70O5 594.962 | |
| YMDB12800 | DG(14:1(9Z)/20:0/0:0) | (2R)-1-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propan-2-yl icosanoate | C37H70O5 594.962 | |
| YMDB01723 | Kaempferol 3-O-glucoside | 5-hydroxy-2-(4-hydroxyphenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7-{[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4H-chromen-4-one | C27H30O15 594.5181 | |
| YMDB14017 | PE(10:0/15:0) | (2-aminoethoxy)[(2R)-3-(decanoyloxy)-2-(pentadecanoyloxy)propoxy]phosphinic acid | C30H60NO8P 593.783 | |
| YMDB13564 | PC(10:0/12:0) | (2-{[(2R)-3-(decanoyloxy)-2-(dodecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium | C30H60NO8P 593.783 | |
| YMDB13854 | PE-NMe(10:0/14:0) | [3-(decanoyloxy)-2-(tetradecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid | C30H60NO8P 593.783 | |
| YMDB13857 | PE-NMe(12:0/12:0) | [2,3-bis(dodecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid | C30H60NO8P 593.783 | |
| YMDB01131 | DG(16:1(9Z)/18:1(9Z)/0:0) | (2R)-1-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropan-2-yl (9Z)-octadec-9-enoate | C37H68O5 592.946 |